Literature DB >> 24233658

Prospective study to compare peri-operative hemodynamic alterations following preparation for pheochromocytoma surgery by phenoxybenzamine or prazosin.

Ritesh Agrawal, Saroj Kanta Mishra, Eesh Bhatia, Anjali Mishra, Gyan Chand, Gaurav Agarwal, Amit Agarwal, Ashok Kumar Verma.   

Abstract

BACKGROUND: Prospective studies comparing the efficacy of selective versus nonselective alpha blockers for preoperative preparation of pheochromocytoma (PCC) are lacking. In this prospective nonrandomized study, we compared the outcome of preoperative preparation with phenoxybenzamine (PBZ) and prazosin (PRZ) in terms of perioperative hemodynamic alterations.
METHODS: The study was conducted at a tertiary referral center from July 2010 to December 2012. Thirty-two patients with PCC underwent operation after adequate preparation with PBZ (n = 15) or PRZ (n = 17). Five pediatric and adolescent patients were excluded because of different hemodynamics in this population. Perioperative monitoring was done for pulse rate (PR) and blood pressure(BP) alterations, occurrence of arrhythmias, and time taken to achieve hemodynamic stability. Groups were compared with the Mann-Whitney test, Student's t test, and the χ2 test as applicable.
RESULTS: Patients in the two groups were similar in age,gender, 24 h urinary metanephrine and normetanephrine levels, and type of procedure. Patients prepared with PRZ had significantly more intraoperative episodes of transient hypertension (systolic BP ≥ 160 mmHg) and hypertensive urgency (BP >180/110 mmHg) (p 0.02, 0.03, respectively). More patients receiving PRZ suffered from transient severe hypertension (SBP ≥ 220 mmHg) (p 0.03). The PRZ group also had more median maximum SBP (233 mmHg vs PBZ 181.5 mmHg) (p = 0.01) and lesser median minimum SBP (71 mmHg vs PBZ 78 mmHg) (p 0.03). No significant differences were found between the study groups for changes in PR, postoperative BP alterations,occurrence of arrhythmias, and time taken to achieve hemodynamic stability.
CONCLUSIONS: PBZ was found superior to PRZ in having fewer intraoperative hemodynamic fluctuations.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24233658     DOI: 10.1007/s00268-013-2325-x

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  20 in total

1.  Perioperative risk factors, morbidity, and outcome of 145 patients during phaeochromocytoma resection.

Authors:  M R Kazic; V R Zivaljevic; Z B Milan; I R Paunovic
Journal:  Acta Chir Belg       Date:  2011 Jul-Aug       Impact factor: 1.090

2.  Hemodynamic instability during resection of pheochromocytoma in MEN versus non-MEN patients.

Authors:  Anouk Scholten; Menno R Vriens; Geert Jan E Cromheecke; Inne H M Borel Rinkes; Gerlof D Valk
Journal:  Eur J Endocrinol       Date:  2011-04-15       Impact factor: 6.664

3.  Selective α1-adrenoceptor antagonist (controlled release tablets) in preoperative management of pheochromocytoma.

Authors:  Yu Zhu; Hong-chao He; Ting-wei Su; Yu-xuan Wu; Wei-qing Wang; Ju-ping Zhao; Zhoujun Shen; Chong-yu Zhang; Wen-bin Rui; Wen-long Zhou; Fu-kang Sun; Guang Ning
Journal:  Endocrine       Date:  2010-07-18       Impact factor: 3.633

4.  Adrenergic blockade with phenoxybenzamine and propranolol in a cohort of 60 patients undergoing surgery for phaeochromocytoma.

Authors:  R Mihai; G P Sadler; H Bridge
Journal:  Eur J Anaesthesiol       Date:  2008-06       Impact factor: 4.330

5.  Comparison of two preoperative medical management strategies for laparoscopic resection of pheochromocytoma.

Authors:  Toby N Weingarten; Juan P Cata; Jerome F O'Hara; David J Prybilla; Tasha L Pike; Geoffrey B Thompson; Clive S Grant; David O Warner; Emmanuel Bravo; Juraj Sprung
Journal:  Urology       Date:  2010-05-23       Impact factor: 2.649

6.  Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection.

Authors:  M A Kinney; M E Warner; J A vanHeerden; T T Horlocker; W F Young; D R Schroeder; P M Maxson; M A Warner
Journal:  Anesth Analg       Date:  2000-11       Impact factor: 5.108

7.  Endoscopic treatment of solitary, bilateral, multiple, and recurrent pheochromocytomas and paragangliomas.

Authors:  Martin K Walz; Klaus Peitgen; Hartmut P H Neumann; Onno E Janssen; Thomas Philipp; Klaus Mann
Journal:  World J Surg       Date:  2002-06-06       Impact factor: 3.352

8.  Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005.

Authors:  Karel Pacak; Graeme Eisenhofer; Håkan Ahlman; Stefan R Bornstein; Anne-Paule Gimenez-Roqueplo; Ashley B Grossman; Noriko Kimura; Massimo Mannelli; Anne Marie McNicol; Arthur S Tischler
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2007-02

9.  Prazosin in the diagnosis and treatment of pheochromocytoma.

Authors:  J M Wallace; D P Gill
Journal:  JAMA       Date:  1978-12-15       Impact factor: 56.272

10.  Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma.

Authors:  Cedric Prys-Roberts; John R Farndon
Journal:  World J Surg       Date:  2002-06-19       Impact factor: 3.352

View more
  19 in total

1.  Improvement of preoperative management in patients with adrenal pheochromocytoma.

Authors:  Jiang Li; Chang-Hai Yang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 2.  Factors affecting the haemodynamic behaviour of patients undergoing pheochromocytoma and paraganglioma removal: A review.

Authors:  Rashmi Ramachandran; Vimi Rewari
Journal:  Cardiovasc Endocrinol       Date:  2017-05-17

3.  High pre-operative urinary norepinephrine is an independent determinant of peri-operative hemodynamic instability in unilateral pheochromocytoma/paraganglioma removal.

Authors:  Rita Y K Chang; Brian Hung-Hin Lang; Kai Pun Wong; Chung-Yau Lo
Journal:  World J Surg       Date:  2014-09       Impact factor: 3.352

4.  A rare cause of hypertension in pregnancy: Phaeochromocytoma.

Authors:  Sonali Shah; Lindsay Edwards; Andrew Robinson; Amy Crosthwaite; Christine Houlihan; Kathy Paizis
Journal:  Obstet Med       Date:  2016-10-12

5.  Non-Selective Alpha-Blockers Provide More Stable Intraoperative Hemodynamic Control Compared with Selective Alpha1-Blockers in Patients with Pheochromocytoma and Paraganglioma: A Single-Center Retrospective Cohort Study with a Propensity Score-Matched Analysis from China.

Authors:  Yang Yang; Jie Zhang; Liqun Fang; Xue Jia; Wensheng Zhang
Journal:  Drug Des Devel Ther       Date:  2022-10-17       Impact factor: 4.319

Review 6.  Pheochromocytoma and paraganglioma-an update on diagnosis, evaluation, and management.

Authors:  Amrish Jain; Rossana Baracco; Gaurav Kapur
Journal:  Pediatr Nephrol       Date:  2019-01-02       Impact factor: 3.714

7.  Predictors of hemodynamic instability during surgery for pheochromocytoma.

Authors:  Colleen M Kiernan; Liping Du; Xi Chen; James T Broome; Chanjuan Shi; Mary F Peters; Carmen C Solorzano
Journal:  Ann Surg Oncol       Date:  2014-06-18       Impact factor: 5.344

8.  Selective Versus Non-selective α-Blockade Prior to Laparoscopic Adrenalectomy for Pheochromocytoma.

Authors:  Reese W Randle; Courtney J Balentine; Susan C Pitt; David F Schneider; Rebecca S Sippel
Journal:  Ann Surg Oncol       Date:  2016-08-25       Impact factor: 5.344

9.  Are patients with hormonally functional phaeochromocytoma and paraganglioma initially receiving a proper adrenoceptor blockade? A retrospective cohort study.

Authors:  Henrique Vara Luiz; Mary Jane Tanchee; Maria G Pavlatou; Run Yu; Joan Nambuba; Katherine Wolf; Tamara Prodanov; Robert Wesley; Karen Adams; Tito Fojo; Karel Pacak
Journal:  Clin Endocrinol (Oxf)       Date:  2016-04-15       Impact factor: 3.478

10.  Refractory hypotension during paraganglioma removal - do we have to worry?

Authors:  Rashmi Ramachandran; Vimi Rewari; Shikha Jain; Rajeev Kumar
Journal:  Indian J Anaesth       Date:  2016-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.